Funding Agreements in the Pharmaceuticals Industry
19 Contracts & Agreements
- ALIMERA SCIENCES INC (0 contracts)
- Allergan, plc (1)
- AUXILIUM PHARMACEUTICALS INC (1)
- Bristol-Myers Squibb (1)
- GridIron BioNutrients, Inc. (1)
- Lannett Company, Inc. (2)
- MJ Holdings, Inc. (1)
- Novan, Inc. (1)
- OMEROS CORP (1)
- PONIARD PHARMACEUTICALS, INC. (1)
- Pulmatrix, Inc. (1)
- Roivant Sciences Ltd. (2)
- Sonoma Pharmaceuticals, Inc. (1)
- Terra Tech Corp. (2)
- Tribute Pharmaceuticals Canada Inc. (1)
- VALEANT PHARMACEUTICALS INTERNATIONAL (1)
- VIVUS INC (1)
- Factoring Agreement, effective December 1, 2022, by and among CSNK Working Capital Finance Corp. d/b/a Bay View Funding, and EPI Health, LLC (Novan, Inc., Filed With SEC on December 6, 2022)
- Corporate Advisory Agreement (M&A and Funding) between the Company and GYB, LLC dated May 18, 2021 (MJ Holdings, Inc., Filed With SEC on May 21, 2021)
- First Amendment to Funding Agreement dated as of October 11, 2018, by and between Dermavant Sciences GmBH and NovaQuest Co-Investment Fund VIII, L.P (Roivant Sciences Ltd., Filed With SEC on May 14, 2021)
- Funding Agreement, dated as of July 10, 2018, by and between Demavant Sciences GmBH and NovaQuest Co-Investment Fund VIII, L.P (Roivant Sciences Ltd., Filed With SEC on May 14, 2021)
- Libertas Participation Agreement, dated April 27, 2020, by and between the Gridiron BioNutrients, Inc. and Libertas Funding, LLC, a Connecticut Limited Liability Company (GridIron BioNutrients, Inc., Filed With SEC on May 5, 2020)
- Bridge Facility Commitment Letter, dated as of January 2, 2019, among Morgan Stanley Senior Funding, Inc., MUFG Bank, Ltd. and Bristol-Myers Squibb Company (Bristol-Myers Squibb, Filed With SEC on January 4, 2019)
- Funding Agreement, dated as of October 30, 2017 (Terra Tech Corp., Filed With SEC on November 1, 2017)
- Funding Agreement, dated as of October 30, 2017 (Terra Tech Corp., Filed With SEC on November 1, 2017)
- MORGAN STANLEY SENIOR FUNDING, INC. 1585 Broadway New York, New York 10036 ROYAL BANK OF CANADA 200 Vesey Street New York, New York 10281 CITIGROUP GLOBAL MARKETS INC. 388... (Lannett Company, Inc., Filed With SEC on September 25, 2015)
- MORGAN STANLEY SENIOR FUNDING, INC. 1585 Broadway New York, New York 10036 (Lannett Company, Inc., Filed With SEC on September 4, 2015)
- ACTAVIS FUNDING SCS $21,000,000,000 (Allergan, plc, Filed With SEC on March 6, 2015)
- FUNDING AGREEMENT (Pulmatrix, Inc., Filed With SEC on February 24, 2014)
- FUNDING AGREEMENT (Sonoma Pharmaceuticals, Inc., Filed With SEC on February 6, 2014)
- MORGAN STANLEY SENIOR FUNDING, INC. 1585 Broadway New York, New York 10036 (AUXILIUM PHARMACEUTICALS INC, Filed With SEC on June 13, 2013)
- MidCap Funding III, LLC 7255 Woodmont Ave., Suite 200 Bethesda, Maryland 20814 (Tribute Pharmaceuticals Canada Inc., Filed With SEC on March 22, 2013)
- GOLDMAN SACHS BANK USA GOLDMAN SACHS LENDING PARTNERS LLC 200 West Street New York, New York 10282 MORGAN STANLEY SENIOR FUNDING, INC. 1585 Broadway New York, New York 10036... (VALEANT PHARMACEUTICALS INTERNATIONAL, Filed With SEC on June 23, 2010)
- FUNDING AGREEMENT (OMEROS CORP, Filed With SEC on May 15, 2009)
- FIRST AMENDMENT TO FUNDING AND ROYALTY AGREEMENT (VIVUS INC, Filed With SEC on March 19, 2009)
- RESEARCH FUNDING AND OPTION AGREEMENT by and between THE SCRIPPS RESEARCH INSTITUTE, a California nonprofit public benefit corporation and NEORX CORPORATION, a Washington... (PONIARD PHARMACEUTICALS, INC., Filed With SEC on November 9, 2005)
